Codice QR

Dipeptidyl peptidase IV inhibitors and the risk of mycobacterial pulmonary infections in type 2 diabetes mellitus

Background: Type 2 diabetes mellitus (DM) is a risk factor for mycobacterial pulmonary infections (MPI), including tuberculosis (TB) and nontuberculous mycobacterial lung disease (NTM-LD). Dipeptidyl peptidase IV inhibitor (DPP4i), a common DM medication, has an immune-modulation effect that raises...

Descrizione completa

Salvato in:
Autori principali: Cheng-Yi Wang, Kuang-Ming Liao, Ya-Hui Wang, Kuang-Hung Chen, Shulin Chuang, Chia-Jung Liu, Chin-Chung Shu, Hao-Chien Wang
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2023-11-01
Serie:Journal of Infection and Public Health
Soggetti:
Diabetes mellitus
Dipeptidyl peptidase IV inhibitors
Nontuberculous mycobacterial lung disease
Mycobacterial pulmonary infection
Tuberculosis
Accesso online:http://www.sciencedirect.com/science/article/pii/S187603412300285X
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi